Cargando…
USP51/PD‐L1/ITGB1‐deployed juxtacrine interaction plays a cell‐intrinsic role in promoting chemoresistant phenotypes in non‐small cell lung cancer
BACKGROUND: Programmed death ligand 1 (PD‐L1) has been demonstrated to facilitate tumor progression and therapeutic resistance in an immune‐independent manner. Nevertheless, the function and underlying signaling network(s) of cancer cell‐intrinsic PD‐L1 action remain largely unknown. Herein, we soug...
Autores principales: | Li, Jianjun, Xiao, Xuechun, Ou, Yang, Cao, Lixia, Guo, Min, Qi, Chunchun, Wang, Zhaoyang, Liu, Yuxin, Shuai, Qiuying, Wang, Hang, Sun, Peiqing, Shi, Yi, Yang, Guang, Yang, Shuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354416/ https://www.ncbi.nlm.nih.gov/pubmed/37386737 http://dx.doi.org/10.1002/cac2.12460 |
Ejemplares similares
-
CDK4/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism
por: Zhang, Zhen, et al.
Publicado: (2020) -
Correction to: CDK4/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism
por: Zhang, Zhen, et al.
Publicado: (2020) -
Biochanin A inhibits lung adenocarcinoma progression by targeting ZEB1
por: Li, Jianjun, et al.
Publicado: (2022) -
Juxtacrine regulation of cellular senescence
por: Narita, Masashi
Publicado: (2019) -
D5.1 Evaluation of Initial Flagship Deployments
por: The Helix Nebula Collaboration
Publicado: (2013)